ARCHIVES

Letter to the Editor: IOM Study Welcome For “Omic” Research

This article is from The Cancer Letter archive.

Vol. 36 No. 39 | October 29, 2010

Download PDF Visit The Full Archive

Related Articles

Amgen Claimed QOL Benefit Despite FDA Label Change.

May 18, 2007

Mark Israel To Direct Norris Cotton Center

October 19, 2001

In Brief: DOD Bill includes $135M For breast Cancer, $45M For prostate Cancer Technologies

October 3, 1997

Not All Women Benefitting From Less Invasive Staging

April 25, 2008

Pao Named Director of Department Of Hematology And Oncology At Vanderbilt University

September 30, 2011

Correction: Appropriations Reports Included Language of Minorities and Underserved

October 15, 1999